Therapy for digital ulcers in patients with systemic scleroderma

As of now, there are several pharmacological directions in the treatment and prevention of Raynaud’s syndrome and digital ulcers, including various vasoactive drugs (calcium channel blockers, intravenous prostanoids, endothelin receptor antagonists, phosphodiesterase 5 inhibitors, antiplatelets, and...

Full description

Bibliographic Details
Main Authors: M. N. Starovoitova, O. V. Desinova
Format: Article
Language:Russian
Published: IMA PRESS LLC 2019-01-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/2656